Similar Posts
Development of a Multi-API (Multiparticulate) Fixed-Dose Combination Drug
Abstract: This case study provides a deep dive into Hycon’s achievement in developing a multi-API (Active Pharmaceutical Ingredient) fixed-dose combination oral drug,…
Enhanced Softgel Coatings for Consumer Products
Coated softgels such as enteric, delayed release and fixed dose combinations are an ideal solution for protecting the active ingredients from the…
Improving Therapeutic Compound Oral Bioavailability
Poor solubility remains an ongoing challenge in formulation development. Dr. Sridhar Gummudaveli, Director R &D shares insights on lipid-based drug-delivery systems to…
Customer Requirements for Oral Dose Development
Pharmaceutical developers aim for cost-effective oral medications that work well. This can be challenging, requiring an understanding of client, patient, and provider…
What are Softgels? Different Types, Delivery Methods & Advantages
Softgel capsules have revolutionized the pharmaceutical and nutraceutical industries by offering a versatile and effective delivery method for a wide range of…
How To Create An Bioavailability Enhanced Formulation
Utilizing strategies that conserve active pharmaceutical ingredient (API) quantities and pinpointing scalable formulation technologies suitable for boosting drug solubility and augmenting oral…
